Clinical Engagement Working Group
The Group’s Mission is to foster the use and acceptance of in silico technologies by clinicians and healthcare professionals in both clinical care and health product development.
-
As in silico medicine technologies rapidly evolve, their successful adoption depends on trust, relevance, and usability within clinical practice. To ensure that these transformative tools are developed with and for their primary users, VPH established the Clinical Working Group, focusing on Clinical Community Engagement.
This initiative brings together clinicians, researchers, and healthcare professionals committed to bridging the gap between scientific innovation and day-to-day medical practice.
-
Why it matters
In silico methods are redefining how we design, test, and implement medical interventions. While their potential is vast, these technologies can also be disruptive. Ensuring alignment with clinical needs and workflows is therefore crucial. A recent VPH survey underscored the urgency of raising awareness, facilitating structured consultation, and supporting clinician involvement throughout the innovation process.
-
Focus areas
The Clinical Working Group is dedicated to raising awareness about the potential of in silico technologies while building strong relationships with clinicians, hospitals, and opinion leaders. It works to understand and address the concerns of healthcare professionals, promote the co-design of tools and methods with clinical users, and support regulatory developments that reflect clinical reality.
Who can join?
This group is open to all VPH members, and we particularly encourage clinicians and healthcare professionals to participate. Even non-VPH members from the clinical world are welcome to collaborate. The group meets once a month for a one-hour session, where members actively contribute by shaping documents, drafting articles or communication materials, and helping to amplify the group’s activities within the broader clinical and research community.
If you’re working with clinicians, inviting them to join your network could play a key role in making in silico medicine clinically meaningful.
Ready to get involved? Contact us!
